{"filings":[{"id":97948,"accession_number":"0000031791-26-000016","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Revvity Q1 adj EPS $1.06 beats $1.01 YoY; revenue $711M +7%; plans China IDX divestiture","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 GAAP EPS $0.37 vs $0.35 YoY; adjusted EPS $1.06 vs $1.01; revenue $711M (+7% YoY).","Pro forma (ex-China IDX) revenue $687M, adj EPS $1.04 vs $0.95 YoY.","Signed LOI to sell China Immunodiagnostics business for up to $200M; expects close by 2027.","China IDX represented ~6% of FY2025 total revenue; definitive agreement expected Q2 2026.","Full-year 2026 guidance updated on pro forma basis; management to discuss on call."],"consensus_eps_estimate":null,"consensus_eps_actual":0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":711118000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97947,"accession_number":"0001193125-26-201401","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Revvity shareholders approve bylaw amendment allowing 25% owners to call special meetings; all director nominees elected","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Shareholders approved bylaw amendment allowing 25% owners to call special meetings (99,086,661 for, 440,300 against).","All ten director nominees elected; Peter Barrett received lowest support (93,823,710 for, 5,674,907 against).","Ratified Deloitte & Touche as independent auditor (102,992,151 for, 1,036,994 against).","Advisory say-on-pay approved (94,377,138 for, 3,770,364 against).","Shareholder proposal requiring executive stock ownership rejected (22,974,850 for, 76,502,157 against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113162,"accession_number":"0000031791-26-000007","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q4 revenue $772M (+6% YoY), adj EPS $1.70 vs $1.42; initiates 2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP EPS $0.87 vs $0.78; adjusted EPS from cont. ops. $1.70 vs $1.42.","Full year 2025 revenue $2,856M (+3.7% YoY); GAAP EPS $2.07 vs $2.20; adj. EPS $5.06 vs $4.90.","Q4 organic revenue growth 4%; adj. operating margin 29.7% vs 30.3%.","Company initiates full year 2026 guidance; no specific numbers provided in release."],"consensus_eps_estimate":null,"consensus_eps_actual":2.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":2856051000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113161,"accession_number":"0000031791-26-000003","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Revvity pre-announces Q4 2025 revenue ~$772M, adj. EPS above guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue expected ~$772M, reported +6% and organic +4% YoY.","Full year 2025 revenue expected ~$2,855M, reported +4% and organic +3% YoY.","Full year adjusted EPS expected to exceed prior guidance range of $4.90-$5.00.","Q4 earnings call scheduled for Feb 2, 2026 at 8:00 AM ET.","CEO to present at J.P. Morgan Healthcare Conference on Jan 13, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":2.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":2856051000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129559,"accession_number":"0000031791-25-000032","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2025-10-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q3: revenue $699M (+2%), GAAP EPS $0.40, adjusted EPS $1.18; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $699M, up 2% reported / 1% organic; GAAP EPS $0.40 vs $0.77 a year ago.","Adjusted EPS from continuing ops $1.18 vs $1.28; adjusted operating profit margin 26.1% vs 28.3%.","GAAP operating income $82M (11.7% margin) down from $98M (14.3%) in prior-year quarter.","Reaffirms full-year 2025 organic growth; raises adjusted EPS guidance.","Board authorized new $1B share repurchase program."],"consensus_eps_estimate":null,"consensus_eps_actual":1.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":2083995000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129558,"accession_number":"0001193125-25-249958","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Revvity appoints Anita Gonzales as Vice President and Chief Accounting Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Anita Gonzales appointed as Vice President and Chief Accounting Officer, effective Oct. 23, 2025.","Gonzales served as VP and Controller since May 2023, joined Revvity in March 2021.","Prior roles include GE Director of Audit (2016-2021) and PwC Senior Manager.","She holds a CPA and degrees from the University of Texas at Austin."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146130,"accession_number":"0000031791-25-000022","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q2 revenue $720M (+4% reported), GAAP EPS $0.46, adjusted EPS $1.18; updates FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Revenue $720M, +4% reported and +3% organic; GAAP EPS $0.46 vs $0.45 prior year.","Adjusted EPS $1.18 vs $1.22 YoY; adjusted operating margin 26.6% vs 28.8%.","GAAP operating income $91M, up from $86M; adjusted operating income $192M vs $199M.","Full year 2025 guidance updated; specifics not provided in excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":0.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":1385046000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164442,"accession_number":"0000031791-25-000012","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2025-04-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q1 revenue $665M (+4% organic), GAAP EPS $0.35, adjusted EPS $1.01; reaffirms FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $665M, up 2% reported and 4% organic YoY.","GAAP EPS $0.35 vs $0.21 YoY; adjusted EPS $1.01 vs $0.98.","GAAP operating margin 10.9% (6.8% YoY); adjusted margin 25.6% (25.5% YoY).","Full year 2025 organic growth and adjusted EPS guidance reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":664762000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164441,"accession_number":"0001193125-25-096747","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Shareholders approve majority voting standard and special meeting proposal at Revvity annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders elected all 10 director nominees with over 96% support; no contested election.","Majority voting standard proposal approved with 98.4M for, 0.36M against (excl. broker non-votes).","Shareholder proposal to allow special meetings passed with 66.9M for vs 35.3M against.","Executive compensation non-binding advisory vote passed with 92.8M for (91.5% of votes cast).","Ratification of Deloitte as auditor approved with 103.6M for (98.0% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182202,"accession_number":"0000031791-25-000006","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2025-01-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q4 revenue $729M (+6% organic), adj EPS $1.42; FY adj EPS $4.90","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 revenue $729M (+5% reported, +6% organic); GAAP EPS $0.78 (vs $0.64); adjusted EPS $1.42 (vs $1.25).","Full year 2024 revenue $2,755M (flat YoY); GAAP EPS $2.20 (down from $5.55); adjusted EPS $4.90 (up from $4.65).","Q4 adjusted operating margin 30.3% (vs 27.5%); full year adjusted margin 28.3% (vs 28.0%).","Company initiates full year 2025 guidance; specific numbers not included in the press release excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":2.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":2755026000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182201,"accession_number":"0000031791-25-000003","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Revvity provides preliminary Q4 revenue ~$730M, 6% organic growth; EPS guidance reaffirmed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 preliminary revenue ~$730M; reported growth ~5%, organic ~6% vs. prior year.","Full-year 2024 adjusted EPS expected to meet or exceed guidance provided Nov 4, 2024.","Q4 and full-year 2024 results to be released Jan 31, 2025; conference call at 8am ET.","CEO Prahlad Singh to present at J.P. Morgan Healthcare Conference on Jan 13, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":2.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":2755026000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182200,"accession_number":"0001193125-25-002871","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2025-01-07T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Revvity enters new $1.5B revolving credit facility maturing 2030, replaces prior facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $1.5B unsecured revolver matures Jan 7, 2030; replaces prior $1.5B facility due Aug 2026.","No borrowings outstanding at closing; only $4.2M in letters of credit outstanding.","Interest rate based on debt ratings: term SOFR + spread 0.795%-1.425%; facility fee 0.08%-0.20%.","Joint lead arrangers: BofA Securities, JPMorgan, Goldman Sachs, PNC Capital Markets, Wells Fargo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198829,"accession_number":"0000031791-24-000026","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2024-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q3 GAAP EPS $0.77, adj. EPS $1.28; raises FY guidance; $1B buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $684M, +2% reported and organic YoY; GAAP operating margin 14.3% vs 10.3%.","GAAP EPS $0.77 vs $0.08 a year ago; adjusted EPS from continuing ops $1.28 vs $1.18.","Adjusted operating margin 28.3% vs 27.5%; adjusted operating income $193M.","Raises full-year 2024 adjusted EPS guidance (specific figures not disclosed in release).","Board authorizes new $1B share repurchase program; investor day set for Nov 21, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":1.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":2025654000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214870,"accession_number":"0000031791-24-000018","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2024-07-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q2 2024: GAAP EPS $0.45, Adj EPS $1.22; raises full-year adj EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $692M (-2% reported, -1% organic); GAAP EPS $0.45 vs $0.28 YoY.","Adjusted EPS $1.22 vs $1.21 YoY; adj operating margin 28.7% (vs 28.8%).","Raises full-year 2024 adjusted EPS guidance (no numeric range disclosed).","GAAP operating income $86M (12.4% margin) vs $78M (11.0%) YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":1341605000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234044,"accession_number":"0001628280-24-018795","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2024-04-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q1 revenue down 4% to $650M; GAAP EPS $0.21 vs $4.50; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $650M, -4% reported, -3% organic; GAAP EPS $0.21 vs $4.50 (prior year included large gain from discontinued ops).","Adjusted EPS from continuing ops $0.98 vs $1.01; adjusted operating margin 25.5% vs 28.0%.","GAAP operating income $44M, margin 6.8%; adjusted operating income $166M, margin 25.5%.","Reaffirmed full-year 2024 organic growth and adjusted EPS guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":649920000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234043,"accession_number":"0001193125-24-110060","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Revvity annual meeting approves all proposals, including director elections and say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 10 director nominees elected with majority support; Chapin received most votes (101.9M), Witney fewest (98.7M).","Ratification of Deloitte & Touche as auditor passed: 100.4M for, 6.7M against.","Advisory vote on executive compensation approved: 98.0M for, 4.4M against, 4.4M broker non-votes.","Shareholder proposal to adopt simple majority voting standard passed: 98.7M for, 3.4M against.","Meeting held April 23, 2024; results reflect routine governance matters with no unexpected outcomes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251996,"accession_number":"0001157523-24-000146","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2024-02-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Revvity Q4 revenue $696M (-6%), adjusted EPS $1.25 vs $1.41; full year adjusted EPS $4.65 vs $6.92","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP EPS $0.64 vs $1.01; adjusted EPS $1.25 vs $1.41; revenue down 6% reported, 7% organic.","Full year 2023 GAAP EPS $5.55 vs $4.50; adjusted EPS $4.65 vs $6.92; revenue $2,751M (-17%).","Q4 GAAP operating margin 11.1% (vs 18.5%); adjusted operating margin 27.5% (vs 32.3%).","Full year adjusted operating margin 28.0% vs 36.6% in 2022; non-COVID organic revenue -3% in Q4.","Company initiates full year 2024 guidance; specific numbers not disclosed in this excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":5.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":2750571000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251995,"accession_number":"0001157523-24-000120","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2024-01-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Revvity elects two new directors; Dr. Sylvie Grégoire not seeking re-election","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Sylvie Grégoire not standing for re-election at the 2024 annual meeting on Apr 23; no disagreement with company.","Board elected Michael A. Klobuchar and Sophie V. Vandebroek as directors, effective Feb 1, 2024.","New directors receive prorated annual equity ($22,500 stock + $27,500 RSU) and prorated cash retainer of $90,000.","Neither Klobuchar nor Vandebroek will initially serve on a board committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251994,"accession_number":"0001157523-24-000035","cik":31791,"company_name":"REVVITY, INC.","ticker":"RVTY","form_type":"8-K","filed_at":"2024-01-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Revvity issues preliminary Q4 2023 revenue at least $690M with organic decline of 4-7%, EPS guidance reaffirmed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 revenue expected at least $690M, reported organic revenue decline of approx. 7% and non-COVID organic decline of 4% year-over-year.","Full-year 2023 adjusted EPS expected to meet or exceed the guidance provided on October 30, 2023.","Company will release Q4 and full-year 2023 results on February 1, 2024, with a conference call at 8:00 a.m. ET hosted by CEO Prahlad Singh.","CEO Prahlad Singh presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":5.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":2750571000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":10797870952.86337,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}